• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Evaluation of fatty acid metabolism-related gene expression in non-alcoholic fatty liver disease

Research Project

Project/Area Number 17590658
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Gastroenterology
Research InstitutionKyushu Medical Center, National Hospital Organization (2006)
Kyushu University (2005)

Principal Investigator

NAKAMUTA Makoto  Kyushu Medical Center, National Hospital Organization, Department of Gastroenterology, Chief, 消化器科, 医長 (00294918)

Co-Investigator(Kenkyū-buntansha) ENJOJI Munechika  Kyushu University Hospital, Assistant Professor, 大学病院, 助手 (20253411)
KOTOH Kazuhiro  Kyushu University Hospital, Assistant Professor, 大学病院, 助手 (80289579)
INOGUCHI Toyoshi  Kyushu University Hospital, Associate Professor, 大学病院, 講師 (00294926)
Project Period (FY) 2005 – 2006
Project Status Completed (Fiscal Year 2006)
Budget Amount *help
¥3,500,000 (Direct Cost: ¥3,500,000)
Fiscal Year 2006: ¥1,300,000 (Direct Cost: ¥1,300,000)
Fiscal Year 2005: ¥2,200,000 (Direct Cost: ¥2,200,000)
KeywordsNAFLD / NASH / Fatty liver / Fatty acid metabolism / Oxidation / ROS / Insulin / AMPK / 脂肪酸合成 / 脂肪酸酸化 / ROS / SREBP1
Research Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent causes of abnormal liver dysfunction and its prevalence has markedly increased. We previously evaluated the expression of fatty acid metabolism-related genes in NAFLD and reported changes in expression that could contribute to increased fatty acid synthesis in NAFLD. In the present study, we evaluated the expression of additional fatty acid metabolism-related genes in larger groups of NAFLD (n=26) and normal liver (n=10) samples. The target genes for real-time PCR analysis were as follows: acetyl-CoA carboxylase (ACC) 1, ACC2, fatty acid synthase (FAS), sterol regulatory element-binding protein lc (SREBP1c), and adipose differentiation-related protein (ADRP) for evaluation of de novo synthesis and uptake of fatty acids; carnitine palmitoyltransferase la (CPT1a), long-chain acyl-CoA dehydrogenase (LCAD), long-chain L-3-hydroxyacyl-coenzyme A dehydrogenase α (HADHα), uncoupling protein 2 (UCP2), straight-chain acyl-CoA … More oxidase (ACOX), branched-chain acyl-CoA oxidase (BOX), cytochrome P450 2E1 (CYP2E1), CYP4A11, and peroxisome proliferator-activated receptor (PPAR) α for oxidation in the mitochondria, peroxisome and microsome; superoxide dismutase (SOD), catalase, and glutathione synthetase (GSS) for antioxidant pathways; diacylglycerol O-acyltransferase 1 (DGAT1), PPARγ, and hormone sensitive lipase (HSL) for triglyceride synthesis and catalysis. In NAFLD, although fatty acids accumulated in hepatocytes, their de novo synthesis and uptake were up-regulated in association with increased expression of ACC1, FAS, SREBP1c, and ADRP. Fatty acids oxidation-related genes, LCAD, HADHα, UCP2, ACOX, BOX, CYP2E1, and CYP4A11, were all over-expressed, indicating that oxidation was enhanced in NAFLD, whereas the expression of CTP1a and PPARα was decreased. Furthermore, SOD and catalase were also over-expressed, indicating that antioxidant pathways are activated to neutralize reactive oxygen species (ROS), which are overproduced during oxidative processes. The expression of DGAT1 was upregulated without increased PPARγ expression, whereas the expression of HSL was decreased. Our data indicated the following regarding NAFLD : 1) Increased de novo synthesis and uptake of fatty acids lead to further fatty acid accumulation in hepatocytes. 2) Mitochondrial fatty acid oxidation is decreased or fully activated. 3) In order to complement the function of mitochondria (β-oxidation), peroxisomal (β-oxidation) and microsomal (ω-oxidation) oxidation was up-regulated to decrease fatty acid accumulation. 4) Antioxidant pathways including SOD and catalase were enhanced to neutralize ROS overproduced during mitochondria, peroxisomal, and microsomal oxidation. 5) Lipid droplet formation was enhanced due to increased DGAT expression and decreased HSL expression. Further studies will be needed to clarify how fatty acid synthesis is increased by SREBP1c, which is under the control of insulin and AMP-activated protein kinase. Less

Report

(3 results)
  • 2006 Annual Research Report   Final Research Report Summary
  • 2005 Annual Research Report
  • Research Products

    (10 results)

All 2006 2005

All Journal Article (5 results) Book (5 results)

  • [Journal Article] インスリン抵抗性とメタボリックシンドローム2006

    • Author(s)
      中牟田 誠
    • Journal Title

      肝胆膵 2006;53:335-340 53

      Pages: 335-340

    • Related Report
      2006 Annual Research Report
  • [Journal Article] Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.2005

    • Author(s)
      Nakamuta M, et al.
    • Journal Title

      Int J Mol Med 16(4)

      Pages: 635-651

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] インスリン抵抗性とメタボリックシンドローム2005

    • Author(s)
      中牟田 誠
    • Journal Title

      肝胆膵 2006;53 : 335-340 53

      Pages: 335-340

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.2005

    • Author(s)
      Nakamuta M, Kohjima M, Morizono S, Kotoh K, Yoshimoto T, Miyagi I, Enjoji M.
    • Journal Title

      Int J Mol Med. 16(4)

      Pages: 631-5

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Journal Article] Evaluation of fatty acids metabolism-related genes expression in nonalcoholic fatty liver diseases2005

    • Author(s)
      Nakamuta M, et al.
    • Journal Title

      International Journal of Molecular Medicine 16

      Pages: 631-635

    • Related Report
      2005 Annual Research Report
  • [Book] 脂肪酸代謝と肝障害 別冊・医学のあゆみ 消化器疾患-State of Arts II 肝・胆・膵(竹井謙之、川崎誠治 編)2006

    • Author(s)
      中牟田 誠
    • Publisher
      医歯薬出版株式会社
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Book] NAFLDにおける脂肪酸代謝 別冊・医学のあゆみ NAFLDのすべて (西原利治 編)2006

    • Author(s)
      中牟田 誠
    • Publisher
      医歯薬出版株式会社
    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2006 Final Research Report Summary
  • [Book] 脂肪酸代謝と肝障害 別冊・医学のあゆみ 消化器疾患 II 肝・胆・膵(竹井謙之, 川崎誠治編)2006

    • Author(s)
      中牟田 誠
    • Publisher
      医歯薬出版株式会社
    • Related Report
      2006 Annual Research Report
  • [Book] NAFLDにおける脂肪酸代謝 別冊・医学のあゆみ NAFLDのすべて (西原利治編)2006

    • Author(s)
      中牟田 誠
    • Publisher
      医歯薬出版株式会社
    • Related Report
      2006 Annual Research Report
  • [Book] NAFLDのすべて2006

    • Author(s)
      中牟田誠, 国府島庸之
    • Publisher
      医歯薬出版株式会社
    • Related Report
      2005 Annual Research Report

URL: 

Published: 2005-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi